Literature DB >> 673170

Iodide and xenon enhancement of computed tomography (CT) in multiple sclerosis (MS).

E W Radue, B E Kendall.   

Abstract

The characteristic findings on computed tomography (CT) in multiple sclerosis (MS) are discussed. In a series of 49 cases plain CT was normal in 21 (43%), cerebral atrophy alone was present in 17 (35%) and plaques were visible in 11 (23%). These were most often adjacent to the lateral ventricles (14 plaques) and in the parietal white matter (10 plaques). CT was performed after the intravenous administration of iodide in 16 of these cases. Three of the low attenuation and three additional isodense lesions enhanced. Two patients with low attenuation plaques were scanned with xenon enhancement; the plaques absorbed less xenon than the corresponding contralateral brain substance and additional, previously isodense plaques were revealed. In one case the white matter absorbed much less xenon than normal and its uptake relative to grey matter was reduced.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 673170     DOI: 10.1007/BF00329059

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  7 in total

1.  BLOOD-BRAIN BARRIER DAMAGE IN MULTIPLE SCLEROSIS SUPRAVITAL TEST-OBSERVATIONS.

Authors:  T BROMAN
Journal:  Acta Neurol Scand Suppl       Date:  1964

2.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

3.  The anesthetic properties of xenon in animals and human beings, with additional observations on krypton.

Authors:  S C CULLEN; E G GROSS
Journal:  Science       Date:  1951-05-18       Impact factor: 47.728

4.  Computer subtraction in regional cerebral blood-volume measurements using the EMI-Scanner.

Authors:  E Zilkha; G Ladurner; L D Iliff; G H Du Boulay; J Marshall
Journal:  Br J Radiol       Date:  1976-04       Impact factor: 3.039

5.  Plaque of multiple sclerosis seen on computerized transaxial tomogram.

Authors:  M Cole; R J Ross
Journal:  Neurology       Date:  1977-09       Impact factor: 9.910

6.  Computer tomography of the cerebrum in multiple sclerosis.

Authors:  C Gyldensted
Journal:  Neuroradiology       Date:  1976-10-27       Impact factor: 2.804

7.  Xenon inhalation as an adjunct to computerized tomography of the brain: preliminary study.

Authors:  S S Winkler; J F Sackett; J E Holden; D C Flemming; S C Alexander; M Madsen; R I Kimmel
Journal:  Invest Radiol       Date:  1977 Jan-Feb       Impact factor: 6.016

  7 in total
  7 in total

1.  Central nervous system involvement in optic neuritis.

Authors:  E A Sanders; J P Reulen; L A Hogenhuis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-03       Impact factor: 10.154

2.  Detection of demyelinated plaques with xenon-enhanced computed tomography.

Authors:  V Haughton; J Schmidt; A Syvertsen; B Khatri; K C Ho; C Wilson
Journal:  Neuroradiology       Date:  1980-12       Impact factor: 2.804

3.  Cranial computed tomography in the diagnosis of multiple sclerosis.

Authors:  L A Loizou; E B Rolfe; H Hewazy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

4.  Structural brain correlates of anterograde memory deficits in multiple sclerosis.

Authors:  M Brainin; G Goldenberg; C Ahlers; T Reisner; A Neuhold; L Deecke
Journal:  J Neurol       Date:  1988-07       Impact factor: 4.849

5.  CT and EEG investigations in 100 patients with multiple sclerosis (MS).

Authors:  A Quattrini; A Paggi; A Ortenzi; P Di Bella; F Cianci; L Forastieri
Journal:  Ital J Neurol Sci       Date:  1981-01

6.  Difficulties in diagnosis of supratentorial gliomas by CAT scan.

Authors:  B E Kendall; J Jakubowski; P Pullicino; L Symon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-06       Impact factor: 10.154

7.  Multiple sclerosis with clinical and radiological features of cerebral tumour.

Authors:  H J Sagar; C P Warlow; P W Sheldon; M M Esiri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.